Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT00792506 · TERMINATED

Trial details

NCT number: NCT00792506
Sponsor: Italfarmaco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-10-01
Primary completion: 2010-01-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.